| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
|
N Engl J Med
|
2005
|
12.99
|
|
2
|
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
|
Lancet Oncol
|
2008
|
8.70
|
|
3
|
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
|
J Clin Oncol
|
2007
|
7.45
|
|
4
|
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
|
Lancet
|
2013
|
7.25
|
|
5
|
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.
|
Lancet Oncol
|
2010
|
5.93
|
|
6
|
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
|
N Engl J Med
|
2015
|
4.53
|
|
7
|
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
|
N Engl J Med
|
2009
|
4.16
|
|
8
|
Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
|
J Natl Cancer Inst
|
2007
|
4.11
|
|
9
|
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.
|
J Clin Oncol
|
2011
|
4.09
|
|
10
|
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
|
J Natl Cancer Inst
|
2011
|
3.73
|
|
11
|
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.
|
J Clin Oncol
|
2011
|
3.53
|
|
12
|
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
|
Lancet
|
2013
|
3.31
|
|
13
|
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
|
Lancet Oncol
|
2010
|
3.27
|
|
14
|
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.
|
J Clin Oncol
|
2010
|
2.63
|
|
15
|
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
|
J Clin Oncol
|
2005
|
2.58
|
|
16
|
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
|
Lancet Oncol
|
2011
|
2.51
|
|
17
|
Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.
|
Lancet Oncol
|
2008
|
2.42
|
|
18
|
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors.
|
J Clin Oncol
|
2011
|
2.26
|
|
19
|
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model.
|
Endocr Relat Cancer
|
2007
|
2.01
|
|
20
|
Preventive therapy for breast cancer: a consensus statement.
|
Lancet Oncol
|
2011
|
1.69
|
|
21
|
Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial.
|
J Clin Oncol
|
2011
|
1.66
|
|
22
|
Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial.
|
Crit Care Med
|
2013
|
1.59
|
|
23
|
Recommendations for collection and handling of specimens from group breast cancer clinical trials.
|
J Clin Oncol
|
2008
|
1.50
|
|
24
|
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received.
|
J Vasc Surg
|
2010
|
1.47
|
|
25
|
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
|
J Clin Oncol
|
2008
|
1.34
|
|
26
|
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy.
|
J Vasc Surg
|
2010
|
1.34
|
|
27
|
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study.
|
J Clin Oncol
|
2011
|
1.31
|
|
28
|
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
|
Breast Cancer Res Treat
|
2008
|
1.31
|
|
29
|
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.
|
J Clin Oncol
|
2011
|
1.29
|
|
30
|
Reproducibility of visual assessment on mammographic density.
|
Breast Cancer Res Treat
|
2007
|
1.16
|
|
31
|
Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.
|
BMC Cancer
|
2014
|
1.16
|
|
32
|
Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians).
|
Trials
|
2011
|
1.11
|
|
33
|
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
|
J Clin Oncol
|
2006
|
1.10
|
|
34
|
Community-based stroke incidence in a Scottish population: the Scottish Borders Stroke Study.
|
Stroke
|
2005
|
1.10
|
|
35
|
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.
|
J Clin Oncol
|
2007
|
1.10
|
|
36
|
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making.
|
J Vasc Surg
|
2010
|
1.06
|
|
37
|
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.
|
J Clin Oncol
|
2007
|
1.04
|
|
38
|
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
|
J Clin Oncol
|
2012
|
1.03
|
|
39
|
Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trial.
|
Diabetes Care
|
2011
|
1.02
|
|
40
|
Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial.
|
Trials
|
2012
|
1.01
|
|
41
|
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
|
Breast Cancer Res Treat
|
2008
|
1.00
|
|
42
|
Improving informed consent in clinical trials: successful piloting of a decision aid.
|
J Clin Oncol
|
2007
|
0.86
|
|
43
|
The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.
|
BMC Cancer
|
2014
|
0.84
|
|
44
|
Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer.
|
Breast Cancer Res Treat
|
2012
|
0.84
|
|
45
|
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification.
|
J Vasc Surg
|
2010
|
0.83
|
|
46
|
Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types.
|
Lancet Oncol
|
2011
|
0.81
|
|
47
|
Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
|
J Natl Cancer Inst
|
2006
|
0.80
|
|
48
|
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
|
Breast Cancer Res Treat
|
2012
|
0.79
|
|
49
|
Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes.
|
BMJ Open
|
2013
|
0.79
|
|
50
|
A rehabilitation intervention to promote physical recovery following intensive care: a detailed description of construct development, rationale and content together with proposed taxonomy to capture processes in a randomised controlled trial.
|
Trials
|
2014
|
0.79
|
|
51
|
Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.
|
Breast Cancer Res Treat
|
2003
|
0.78
|
|
52
|
Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus Conference.
|
Ann Surg Oncol
|
2011
|
0.77
|
|
53
|
Risk-targeted selection of agricultural holdings for post-epidemic surveillance: estimation of efficiency gains.
|
PLoS One
|
2011
|
0.75
|
|
54
|
New guidelines on hypertension.
|
Lancet
|
2006
|
0.75
|
|
55
|
Personalization of loco-regional care for primary breast cancer patients (part 1).
|
Future Oncol
|
2015
|
0.75
|
|
56
|
Systemic adjuvant therapies for early breast cancer: 15-year results for recurrence and survival.
|
Med J Aust
|
2005
|
0.75
|
|
57
|
Personalization of loco-regional care for primary breast cancer patients (part 2).
|
Future Oncol
|
2015
|
0.75
|